Influence of competing risks on estimates of recurrence risk and breast cancer-specific mortality in analyses of the Early Breast Cancer Trialists Collaborative Group.

被引：0
|
作者：
Saleh, Ramy
Nadler, Michelle
Desnoyers, Alexandra
Rodin, Danielle Lee
Abdel-Qadir, Husam
Amir, Eitan
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] McMaster Univ, Mcmaster, ON, Canada
[4] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada
[5] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[6] Univ Toronto, Div Cardiol, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
533
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Factors associated with late risks of breast cancer-specific mortality in the SEER registry
    José P. Leone
    Carlos T. Vallejo
    Michael J. Hassett
    Julieta Leone
    Noah Graham
    Nabihah Tayob
    Rachel A. Freedman
    Sara M. Tolaney
    Bernardo A. Leone
    Eric P. Winer
    Nancy U. Lin
    Breast Cancer Research and Treatment, 2021, 189 : 203 - 212
  • [22] The effect of competing mortality on the risk of cancer-specific survival in kidney cancer
    Karakiewicz, PI
    Lewinshtein, DJ
    Perrotte, P
    Brigand, A
    Chun, KHF
    Guille, F
    Lobel, B
    Patard, JJ
    Ficarra, V
    Artibani, W
    Cindolo, L
    Tostain, J
    Chopin, DK
    De La Taille, A
    JOURNAL OF UROLOGY, 2006, 175 (04): : 240 - 240
  • [23] Predictors of Competing Mortality in Early Breast Cancer
    Mell, Loren K.
    Jeong, Jong-Hyeon
    Nichols, Michael A.
    Polite, Blase N.
    Weichselbaum, Ralph R.
    Chmura, Steven J.
    CANCER, 2010, 116 (23) : 5365 - 5373
  • [24] The 20-year results of 5‑year hormone therapy in breast cancer: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
    Traub L.
    Thill M.
    Nitschmann S.
    Der Internist, 2018, 59 (4): : 410 - 412
  • [25] Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy
    Wang, Chengshi
    Hu, Kejia
    Deng, Lei
    He, Wei
    Fang, Fang
    Tamimi, Rulla M.
    Lu, Donghao
    BMC CANCER, 2021, 21 (01)
  • [26] Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy
    Chengshi Wang
    Kejia Hu
    Lei Deng
    Wei He
    Fang Fang
    Rulla M. Tamimi
    Donghao Lu
    BMC Cancer, 21
  • [27] Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk
    Mara A. Schonberg
    Vicky W. Li
    A. Heather Eliassen
    Roger B. Davis
    Andrea Z. LaCroix
    Ellen P. McCarthy
    Bernard A. Rosner
    Rowan T. Chlebowski
    Susan E. Hankinson
    Edward R. Marcantonio
    Long H. Ngo
    Breast Cancer Research and Treatment, 2016, 160 : 547 - 562
  • [28] Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk
    Schonberg, Mara A.
    Li, Vicky W.
    Eliassen, A. Heather
    Davis, Roger B.
    LaCroix, Andrea Z.
    McCarthy, Ellen P.
    Rosner, Bernard A.
    Chlebowski, Rowan T.
    Hankinson, Susan E.
    Marcantonio, Edward R.
    Ngo, Long H.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (03) : 547 - 562
  • [29] Statin use and risks of breast cancer recurrence and mortality
    Guo, Hanbing
    Malone, Kathleen E.
    Heckbert, Susan R.
    Li, Christopher I.
    CANCER, 2024, 130 (18) : 3106 - 3114
  • [30] Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis
    Yufeng Wang
    Jiayuan Wu
    Hairong He
    Huan Ma
    Liren Hu
    Jiyu Wen
    Jun Lyu
    International Journal of Colorectal Disease, 2020, 35 : 795 - 804
12345